Evangelia K. Kirimis, M.D.

NPI 1073755278ActiveIndividual· Internal Medicine· Los Angeles, CA

Internal Medicine (M.D.) in Los Angeles, California, trained at University of Southern California Keck School of Medicine (class of 2005). In 2024 Medicare paid $1,921,986 for 540 patients, and Part D covered 719 of their prescriptions, 81% of them generic. Astrazeneca Pharmaceuticals LP reported $68.49 in payments in 2025, mostly education.

Overview

NPI	1073755278
Status	Active
Entity type	Individual
Credential	M.D.
Sole proprietor	No
NPI issued	Apr 2, 2009
Last updated in NPPES	Aug 26, 2011

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine Primary	207R00000X	A99632	CA

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Hematology/Oncology (CA)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	540
Services billed	141,378 across 113 procedure codes
Paid by Medicare	$1,921,986

Part D prescriptions in 2024

Prescriptions (claims)	719 · 1,617 30-day fills
Patients	197
Total drug cost	$1,276,140
Generic share	81% of claims

Medicare sources and data years

Education and affiliations

Medical school	University of Southern California Keck School of Medicine
Graduation year	2005
Medicare specialty	Hematology/Oncology
Telehealth	Offers telehealth